Form 4: Veru Inc. Director Katzovitz Acquires 90,000 Options at $0.5021 Exercise Price
SEC Form 4 Filing
Director Loren Mark Katzovitz acquired 90,000 common stock options of Veru Inc. at an exercise price of $0.5021 on May 6, 2025.
Summary
- On May 6, 2025, Loren Mark Katzovitz, a director of Veru Inc., acquired 90,000 common stock options.
- The exercise price for these options is $0.5021.
- The options vest in three equal installments on May 6, 2026, May 6, 2027, and May 6, 2028.
- The expiration date for the options is May 6, 2035.
- Following the transaction, Katzovitz directly owns 90,000 shares of Veru Inc. common stock.
Sentiment
Score: 5
Explanation: The document is a neutral regulatory filing. It doesn't inherently convey positive or negative sentiment, simply reporting a transaction.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company directors.
Stakeholder Impact
- The transaction could have a minor positive impact on shareholder confidence, as it indicates a director's belief in the company's future.
Key Dates
| Date | Description |
|---|---|
| 05/06/2025 | Date of transaction: Katzovitz acquired 90,000 common stock options. |
| 05/06/2026 | First vesting date for one-third of the options. |
| 05/06/2027 | Second vesting date for one-third of the options. |
| 05/06/2028 | Third vesting date for one-third of the options. |
| 05/06/2035 | Expiration date of the options. |
| 05/08/2025 | Date of signature on the Form 4. |
Keywords
Form 4, VERU, Veru Inc., Director, Options, Katzovitz, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.